Introduction
The Notch pathway regulates cell fate specification, differentiation, proliferation and apoptosis (ArtavanisTsakonas et al., 1999) . Notch activates the expression of target genes via CSL factors (Artavanis-Tsakonas et al., 1999; Nickoloff et al., 2003; Miele, 2006) . Notch targets include members of the HES (Artavanis-Tsakonas et al., 1999), HERP (Iso et al., 2001) and HEY (Maier and Gessler, 2000) families, p21
Cip/Waf (Rangarajan et al., 2001) , c-Myc (Klinakis et al., 2006; Weng et al., 2006) , nuclear factor-kB subunits (Cheng et al., 2001) , cyclin-D1 (Ronchini and Capobianco, 2001 ) and cyclin-A (Baonza and Freeman, 2005) . Mammals have four Notch paralogs (Notch-1 through Notch-4) and five Notch ligands (delta-1, 3, 4 and Jagged-1 and 2). Notch also binds non-CSL transcription factors such as HIF1a (hypoxia-inducible factor-1a; Gustafsson et al., 2005) and b-catenin (Hayward et al., 2005) , as well as Nur77, a nuclear-receptor-superfamily protein (Jehn et al., 1999) .
Recent data indicate that Notch signaling is critical in mammary development (Dontu et al., 2004) and in mammary stem cell function and luminal fate commitment (Bouras et al., 2008) . Emerging evidence indicates that Notch signaling is frequently activated in breast cancer (Stylianou et al., 2006) . Notch activity has been suggested to correlate with proliferation, antiapoptosis and tumor progression in breast cancer (Miele, 2008) . High expression of Notch-1 and Jagged-1 is associated with poor prognosis (Reedijk et al., 2005 (Reedijk et al., , 2008 Dickson et al., 2007) . Constitutively active Notch-1 or Notch-4 cause mammary tumors in mice (Gallahan et al., 1996; Gallahan and Callahan, 1997; Callahan and Raafat, 2001; Callahan and Egan, 2004; Kiaris et al., 2004) .
17b-Estradiol (henceforth, E 2 ) promotes the growth of estrogen receptor-a (ERa)-positive breast cancer cells. Canonical ERa-responsive genes contain estrogen-responsive elements (EREs; Green and Carroll, 2007) , whereas other genes recruit ERa through transcription factors such as AP1 or SP1 Jakacka et al., 2001) . Numerous protein complexes participate in ERa-mediated gene regulation (Green and Carroll, 2007) . The best known ER coactivators are p160 family members, including steroid receptor coactivator-1 (SRC-1), AIB1/SRC-3 and SRC-2/TIF2/GRIP1. p160 proteins can recruit other coactivators such as CBP, p300 and P/CAF, which possess histone acetyltransferase activity (Perissi and Rosenfeld, 2005; Green and Carroll, 2007) . The phosphorylation status of ERa regulates its activity (Cenni and Picard, 1999) . ERa can be phosphorylated at multiple serine residues by various kinases, including IKKa (Park et al., 2005) , mitogen-activated protein kinases (Kato et al., 1995; Bunone et al., 1996) and Akt (Martin et al., 2000; Campbell et al., 2001) . IKKa-kinase activity is required for E 2 -mediated ERa phosphorylation and activation of downstream gene expression (Park et al., 2005) .
In addition to E 2 , multiple growth factors such as insulin, IGF-1 and EGF can activate ERa through mitogen-activated protein kinases (Kato et al., 1995; Bunone et al., 1996) ; cyclin-D1, which is frequently overexpressed or amplified in breast cancer, can bind ERa, recruit SRC-family coactivators and activate downstream gene expression in the absence of E 2 (Neuman et al., 1997; Zwijsen et al., 1997) .
We have recently shown that in ERa-positive breast cancer cells E 2 inhibits Notch signaling by modulating Notch activation . Conversely, E 2 deprivation or treatment with 4-hydroxytamoxifen re-activates Notch signaling and increases dependence on it for survival. Notch-1 knockdown causes growth arrest in T47D and MCF-7 cells, and potentiates the effects of 4-hydroxytamoxifen. Treatment of T47D xenografts with a combination of tamoxifen and a pharmacological Notch inhibitor (g-secretase inhibitor (GSI)) caused tumor regression. These observations posed a fundamental question: Does Notch regulate a subset of ERa-target genes?
Results
Active Notch-1 facilitates transcription of ERa-target genes in the absence of E 2 We hypothesized that Notch activation in the absence of E 2 may rescue the expression of some critical E 2 -target genes. Two well-known E 2 -target genes, c-Myc and cyclin-D1, are also potential Notch targets in the mammary gland (Kiaris et al., 2004; Klinakis et al., 2006) . Exploratory reverse transcription-PCR (RT-PCR) array studies indicated that expression of Notch-1IC (NIC) in MCF-7 cells in charcoal-stripped (E 2 -deficient) medium transactivated a number of E 2 -target genes (data not shown). Validation experiments by real-time RT-PCR confirmed that E 2 -target genes vascular endothelial growth factor-a (VEGFa), CD44, cyclin-D1, c-Myc and pS2, and Notch-target gene HEY1, but not b-tubulin, are upregulated by NIC in charcoal-stripped medium (Figure 1a) . We confirmed that E 2 induces the expression of VEGFa, CD44, cyclin-D1, c-Myc and pS2 in the cells used in this study (Supplementary Figure 1) .
We then activated endogenous Notch by co-culturing MCF-7 cells in charcoal-stripped medium with mouse LTK fibroblasts engineered to express Notch ligand Jagged-1 (LTK-JAG1) or control vector-transduced parental fibroblasts (LTK-PAR). After 12 h of coculture, mRNA levels of all tested E 2 targets were significantly upregulated by Jagged-1-expressing fibroblasts as compared with that by control fibroblasts (Figure 1b) , whereas b-tubulin was not affected. Since Jagged-1 could potentially activate all four Notch receptors, we used a specific Notch-1 short interfering RNA (siRNA) and determined that Notch-1 knockdown prevented Jagged-1-expressing fibroblasts from activating pS2 transcription, whereas Notch-2 or Notch-4 siRNA did not affect the stimulation of pS2 expression by Jagged-1 (Supplementary Figure 2) .
Next, we investigated the mechanism of Notchmediated induction of these E 2 -target genes. Sequence analysis revealed putative CSL-binding sites in proximity of ERa-binding elements in these promoters. These elements included canonical EREs, and in the case of cyclin-D1, an AP1 consensus sequence known to mediate ERa recruitment (Shen et al., 2008) . The c-Myc promoter contains an Sp1 site and an ERE half-site (Dubik and Shiu, 1992) within 2 kb of the transcriptional start (Figures 1c-g ). We hypothesized that Notch-1 may be co-recruited with ERa. We performed a series of chromatin immunoprecipitation (ChIP) experiments to detect Notch-1 and ERa at each of those promoters under different conditions. First, we confirmed E 2 -dependent recruitment of ERa to those promoters after short-term E 2 treatment (Figures 1c-g,  left) . Interestingly, E 2 also caused significant recruitment of Notch-1 to the cyclin-D1 promoter, but not any other promoters that we analysed. This may suggest that Notch-1 participates in the transcriptional regulation of Figure 1 Active Notch-1 facilitates the transcription of ERa-target promoters in the absence of E 2 . In all experiments, MCF-7 cells were grown in phenol red-free RPMI containing 10% DCC-fetal bovine serum for 3 days prior to harvest. (a) MCF-7 cells were transiently transfected with the active form of Notch-1 (NIC) or pcDNA vector control. The mRNA levels of VEGFa, CD44, c-MYC, CCND1, pS2, HEY1 and b-tubulin were measured by real-time RT-PCR after 48 h after transfection. Values are expressed as relative fold induction by NIC over pcDNA, after internal normalization for 18S rRNA. (b) MCF-7 cells were co-cultured with mouse fibroblasts expressing Jagged-1 (LTK-JAG1) or vector-transfected controls (LTK-PAR) for 12 h prior to harvest. The mRNA levels of VEGFa, CD44, c-MYC, CCND1, pS2, HEY1 and b-tubulin were measured by real-time RT-PCR using validated human-specific primers. Values are expressed as relative fold induction by LTK-JAG1 over LTK-PAR, after internal normalization for RPL13a mRNA. (c-h) The schematics of the indicated promoters and ChIP assays. Charcoal-stripped MCF-7 cells were treated with 5 nM E 2 or ethanol (vehicle) for 1 h (left), or co-cultured with LTK cells for 3 h (right) before formaldehyde fixation. ChIP assays were performed with antibodies to Notch-1 or ERa, followed by real-time PCR analysis of the indicated regions of each promoter (arrows). Values are expressed as relative fold increase of specific antibody pull-down over IgG control, after normalization for internal control RPL13a. tts, transcription start site; *Po0.001. ChIP, chromatin immunoprecipitation; ERa, estrogen receptor-a; LTK-JAG1, mouse LTK fibroblasts expressing Notched ligand Jagged-1; LTK-PAR, control vector transduced parental fibroblast; NIC, active form of Notch-1 (Notch-1IC); RPMI, Rosewell Park Memorial Institute; RT-PCR, reverse transcription-PCR; VEGF, vascular endothelial growth factor. a subset of E 2 -target genes in the presence of E 2 . When we activated Notch in charcoal-stripped medium by coculturing MCF-7 cells with Jagged-1-expressing mouse fibroblasts, Jagged-1 caused significant increases in promoter occupancy of both Notch-1 and ERa on all the promoters studied (Figures 1c-g, right) . The Figure 1c ). These observations supported the hypothesis that Notch can activate a subset of ERa-target genes under E 2 -free conditions, and that Notch-1 is corecruited to these promoters with ERa.
Notch activation increases ER-dependent transcription
In order to further investigate the molecular mechanism(s) whereby Notch activates ER-dependent transcription, we chose a well-characterized experimental model. The gene for TFF1/pS2 is an extensively studied model of transcriptional regulation by E 2 . Its promoter contains a perfect half-ERE at position À263, which is used by ERa (Jeltsch et al., 1987) as well as other regulatory elements within a relatively short DNA sequence (Nunez et al., 1989; Gillesby et al., 1997) . We detected a putative CSL-binding site at position À240. Real-time RT-PCR experiments showed that pS2 mRNA level was increased by E 2 as expected. This effect was abrogated by fulvestrant, which causes ER degradation ( Figure 2a ). NIC expression in charcoal-stripped medium also significantly stimulated pS2 expression ( Figure 2b ). In the presence of E 2 , NIC did not cause any additional stimulation over that achieved by E 2 . Fulvestrant abolished NIC -mediated stimulation of pS2 expression, suggesting that ER is required for this Notch effect ( Figure 2b ). Conversely, neither E 2 nor fulvestrant affected NIC -induced HEY1 expression (Supplementary Figure 3) . We conducted similar experiments, this time activating Notch by co-culture with Jagged-1-expressing mouse fibroblasts. The results were essentially identical. Jagged-1 stimulation increased pS2 expression in charcoal-stripped medium, but did not further enhance the effects of E 2 . Fulvestrant abolished the effects of Jagged-1 (Figure 2c ). ERa levels were verified by western blotting (Figure 2d ). Control experiments (Supplementary Figure 3) showed that expression of HEY1 mRNA was increased by Jagged-1-expressing cells. Consistent with our published observations , E 2 inhibited HEY1 induction by Jagged-1 and fulvestrant restored it. We then explored the role of Notch-1 in basal pS2 expression. A specific siRNA to Notch-1 was used to knock down Notch-1 expression by approximately 70% (Figure 2e) . Expression of pS2, but not b-tubulin, was dramatically decreased by Notch-1 siRNA in charcoal-stripped medium (Figure 2f ). Similarly, a GSI inhibited pS2 expression in a dosedependent manner (Figure 2g ). The IC 50 for this effect was virtually identical to that for HEY1 inhibition (not shown). These experiments support the hypothesis that Notch-1 regulates pS2 expression in the absence of E 2 , and basal pS2 expression under E 2 -free conditions is Notch-1-dependent.
We investigated the mechanism of this effect by ChIP. Co-culture of MCF-7 cells with Jagged-1-expressing fibroblasts in charcoal-stripped medium caused recruitment of both Notch-1 (Figure 2h ) and ERa (Figure 2i ) to the pS2 promoter. Short-term E 2 treatment reduced the amount of Jagged-1-induced Notch-1 recruitment (Figure 2h ), while increasing ERa as compared with that in the control. Fulvestrant nearly abolished the recruitment of Notch-1 and ERa to the pS2 promoter. We confirmed these results by knocking down ERa via siRNA (Figure 2j ) before co-culture. In control cells transfected with scrambled siRNA, Jagged-1 co-culture caused dramatic upregulation of Notch-1 on the pS2 promoter in charcoal-stripped medium, which was significantly inhibited by E 2 . In cells transfected with ERa siRNA, Jagged-1 did not increase the binding of Notch-1 or ERa on the same promoter in the presence or absence of E 2 (Figure 2k ). These data support a model in which Jagged-1 causes co-recruitment of Notch-1 and ERa to the pS2 promoter, inducing gene expression. Notch-1 recruitment requires ERa even in charcoal-stripped medium, suggesting that unliganded ERa and Notch-1 cooperate in inducing pS2 expression. The inhibition of Notch recruitment by E 2 is consistent with our previous data and suggests a feedback mechanism.
IKKa and its kinase activity are required by Notch-1 for transcriptional activation of ER-dependent genes We have shown that active Notch-1 associates with IKKa, promoting its recruitment to nuclear factor-kBdependent promoters (Song et al., 2008) . IKKa has numerous nuclear functions (Perkins, 2007) , and was described as a necessary component of ERa-dependent transcriptional complexes in the presence of E 2 (Park et al., 2005) . Thus, we investigated whether Notch-1 may stimulate ERa-dependent transcription by facilitating the association of IKKa with ERa in the absence of E 2 . First, we used a specific siRNA to IKKa. IKKa knockdown significantly decreased pS2 mRNA in charcoal-stripped medium (Figures 3a and b) , indicating that MCF-7 cells require not only Notch-1 but also IKKa for basal pS2 expression in the absence of E 2 . To determine whether IKKa is required for Notchmediated activation of ER-dependent transcription, we expressed NIC in the absence of IKKa (Figure 3c ). IKKa knockdown abolished the induction of pS2, but not HEY1, by NIC (Figure 3d ), suggesting that IKKa is important for Notch-mediated activation of pS2 expression, but not for canonical Notch signaling in these cells. To rule out possible siRNA artifacts, we also used a dominant-negative (DN) form of IKKa (AA) in which two crucial catalytic residues are replaced by alanine (Arsura et al., 2003) . We coexpressed DN-IKKa with NIC in MCF-7 cells in charcoal-stripped medium (Figure 3e) , and obtained similar results as with IKKa siRNA: DN-IKKa prevented NIC from activating pS2 but not HEY1 transcription (Figure 3f ). Real-time RT-PCR data were complemented by ChIP experiments in which we activated Notch in MCF-7 cells by co-culture with Jagged-1-expressing fibroblasts in charcoalstripped medium, and measured Notch-1 or ERa occupancy of the pS2 promoter. While Jagged-1 stimulated the binding of Notch-1 and ERa to the promoter, either IKKa siRNA (Figure 3g ) or DN-IKKa (Figure 3h ) completely abolished this effect. Additionally, Jagged-1 co-culture increased the binding of IKKa to the pS2 promoter in the absence of E 2 (Figure 3i ). Taken together, these data support a model in which Jagged-1 stimulates the recruitment of Notch-1, IKKa and ERa to the pS2 promoter. IKKa and its kinase activity are required for Jagged-1-induced promoter recruitment and pS2 transcriptional activation.
SRC-1 and SRC-3 are not required, but CSL and MAML1 are indispensable for the effect of Notch-1 on the pS2 promoter Coactivators SRC-1 and/or SRC-3/AIB1 play an important role in ligand-dependent or independent ERa activation. These coactivators possess histone acetyltransferse activity and recruit additional histone acetyltransferses, such as p300 (Green and Carroll, 2007) . ERa phosphorylation at S118, S167 and other residues increases its affinity for SRC-3 (Likhite et al., 2006) . IKKa is one of the kinases that can phosphorylate ERa S118. Thus, we asked whether Notch-1 can induce the recruitment of SRC-1 or SRC-3 to the pS2 promoter in the absence of E 2 via IKKa. Tamoxifen and its active metabolite 4-hydroxytamoxifen can prevent coactivator recruitment by ERa. ChIP assays showed that E 2 , but not Jagged-1-mediated Notch activation, stimulated SRC-1 and SRC-3 binding to the pS2 promoter (Figures 4a and b) . Thus, these canonical ERa coactivators are dispensable for Notch-1-mediated ERa activation. Consistent with this model, 4-hydro- MCF-7 cells were transfected with IKKa siRNA (g) or DN-IKKa (h) and co-cultured with LTK-JAG1 or LTK-PAR fibroblasts for 3 h. ChIP assays were performed with antibodies to Notch-1 or ERa, followed by real-time PCR analysis of the pS2 promoter; *Pp0.001. (i) MCF-7 cells were co-cultured with LTK-JAG1 or LTK-PAR fibroblasts for 3 h and treated with 5 nM E 2 or ethanol control for 1 h prior to harvest. ChIP assay was performed with IKKa antibody followed by real-time PCR for the pS2 promoter; *Pp0.001. ChIP, chromatin immunoprecipitation; DN-IKKa, the dominant-negative form of IKKa; ERa, estrogen receptor-a; GSI, g-secretase inhibitor; LTK-JAG1, mouse LTK fibroblasts expressing Notched ligand Jagged-1; LTK-PAR, control vector-transduced parental fibroblast; NIC, active form of Notch-1 (Notch-1IC); RT-PCR, reverse transcription-PCR.
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xytamoxifen did not affect pS2 or HEY1 induction by NIC, whereas fulvestrant did (Supplementary Figure 4) . Next, we asked whether canonical Notch partners, CSL and MAML1, are involved in this novel transactivation complex. We downregulated CSL by specific siRNA in charcoal-stripped medium (Figure 4c ) and found that induction of HEY1 (Figure 4d ) or pS2 (Figure 4e ) by Jagged-1 was abolished. Similar results were obtained when we overexpressed a DN form of MAML1 (DN-MAML1), which binds to Notch-1 and CSL but lacks the domain responsible for coactivator recruitment (Weng et al., 2003) . In the presence of DN-MAML1, neither transient transfection of NIC (Figure 4f ), nor Jagged-1 co-culture (Figure 4g ), could activate HEY1 or pS2 expression. ChIP data indicated that CSL and MAML1, but not SRC1, are recruited to the pS2 promoter when Notch is activated in the absence of E 2 (Figure 4h ).
The Notch-1 and ERa transcriptional complexes interact in chromatin-enriched nuclear extracts, leading to MAML-1-dependent p300 recruitment Based on our ChIP results showing that Notch-1 binds to the pS2 promoter in an ER-dependent manner, we hypothesized that the Notch-1 and ERa transcriptional complexes may physically interact on the chromatin. We took two different IP strategies to test In all experiments, MCF-7 cells were grown in charcoal-stripped medium for a total of 3 days. SRC-1 (a) and SRC-3 (b) were detected by ChIP on the pS2 promoter. Charcoal-stripped MCF-7 cells were co-cultured with LTK-JAG1 or LTK-PAR fibroblasts for 3 h, and treated with 5 nM E 2 (1 h) or 1 mM 4-hydroxytamoxifen (24 h Notch activates ERa-dependent transcription L Hao et al this hypothesis. First, we used a quantitative co-IP assay using a chimeric construct comprised of full-length Notch-1 fused at the C-terminus with Renilla luciferase (N1-RL)  Figure 5a ). We immunoprecipitated cytoplasmic extracts and chromatinenriched nuclear extracts from cells transfected with N1-RL, with an ERa-specific antibody or nonspecific IgG. We determined the fraction of luciferase activity immunoprecipitated by anti-ERa as compared with that by nonspecific IgG. We could specifically co-precipitate N1-1RL and ERa in chromatin-enriched nuclear lysates but not in cytoplasmic lysates. N1-RL could also be co-immunoprecipitated with known Notch-binding partners CSL and MAML1, which were used as positive controls (Figure 5c ). Negative controls, glyceraldehyde-3-phosphate dehydrogenase-RL (GAPDH-RL) and Cdc2-RL, could not be co-immunoprecipitated with ERa. Similar results were observed in reverse IP experiments where we transfected cells with an ERa-RL construct and immunoprecipitated luciferase activity with either Notch-1 or CSL antibodies (Figure 5d) .
We confirmed the interaction between ERa and the Notch-1/CSL transcriptional complex by traditional IP-western blot from chromatin-enriched nuclear extracts. Figure 5e shows that Notch-1 and ERa can be co-immunoprecipitated only in nuclear extracts, and CSL is part of the complex. To verify the identity of the Notch-1 band, we used two Notch-1 antibodies to detect the interaction between Notch-1 and ERa: we immunoprecipitated with a polyclonal C-terminal antibody, C-20, or ERa, and detected western blots with either C-20 or a specific antibody to NIC, which recognizes the N-terminal epitope generated by g-secretase cleavage. We confirmed that the Notch-1 band we co-immunoprecipitate with ERa is NIC. This interaction appeared (c) MCF-7 cells were transfected with N1-RL or the negative controls GAPDH-RL (for cytoplasmic proteins) and Cdc2-RL (for nuclear proteins). Cells were harvested after 3 days E 2 starvation and nuclear extraction was performed. Cytoplasmic or nuclear extracts were immunoprecipitated with ERa, CSL and MAML1 antibodies. (d) MCF-7 cells were transfected with ERa-RL or negative controls. Cells were harvested after 3 days E 2 starvation and nuclear extraction was performed. Cytoplasm lysates or nuclear extracts were immunoprecipitated with Notch-1 and CSL antibodies; *Pp0.001. (e) Standard IP-western blot was performed on cytoplasmic or nuclear extracts from MCF-7 cells grown in charcoal-stripped medium for 3 days with antibodies to Notch-1, ERa, and CSL. (f) MCF-7 cells were grown in charcoal-stripped medium for a total of 3 days. Cells were transfected with Notch-1 siRNA or scrambled control, and harvested 48 h after transfection. The efficiency of nuclear extraction was verified by western blotting (left). IP-western blot was performed with antibodies to Notch-1, ERa and IKKa. A 10-ml volume of eluted material from each IP was analysed by western blotting for IKKa or MAML1. ChIP, chromatin immunoprecipitation; ERa, estrogen receptor-a; ERa-RL, Renilla luciferase-tagged ERa; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; N1-RL, Renilla luciferase-tagged Notch-1; siRNA, short interfering RNA.
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L Hao et al to be DNA-dependent, since it was abolished by pretreatment of nuclear lysates with the DNA intercalator ethidium bromide before IP (Supplementary Figure 5) . These data indicate that the Notch-1 and ERa transcriptional complexes are in close proximity to each other and may form a large DNA-bound supramolecular complex. Additionally, IKKa and MAML1 could be detected in association with ERa only when Notch-1 was present (Figure 5f ). Notch-1 knockdown abolished complex formation, and completely prevented the nuclear translocation of IKKa. Interestingly, after Notch-1 knockdown IKKa was found in association with ERa in the cytoplasm but not in the nucleus, indicating that Notch may affect the nuclear localization of ERa in the absence of E 2 . To test this hypothesis, we transfected the MCF-7 cells with the ER-RL construct, and measured luciferase activity in cytoplasmic or nuclear fractions after co-culturing MCF-7 cells with Jagged-1-expressing fibroblasts. We observed significant shift of luciferase activity from the cytoplasm to the nucleus in MCF-7 cells co-cultured with Jagged-1-expressing fibroblasts, which do not express ERa. Western blots on the same lysates confirmed this observation (Supplementary Figure 6) . These data support a model in which Notch-1 is required for chromatin recruitment of IKKa, as we showed in a different model (Song et al., 2008) , and can trigger nuclear migration of ERa in the absence of estrogen.
Notch activation induces recruitment of p300 to the pS2 promoter p300/CBP functions as a coactivator for ERa (Green and Carroll, 2007) and Notch/CSL (Miele, 2006) . SRC-p300 complexes are essential for transcriptional initiation on ER-dependent promoters (Green and Carroll, 2007) . Thus, we explored p300 recruitment to the pS2 promoter upon Notch activation. ChIP experiments showed similar levels of p300 on the pS2 promoter when cells were treated with E 2 or co-cultured with Jagged-1-expressing fibroblasts after 3 days of hormone deprivation (Figures 6a and b) . p300 recruitment was abolished by IKKa siRNA (Figure 6c ). Notch-1 and ERa could be co-immunoprecipitated with p300. This interaction was inhibited by IKKa knockdown (Figure 6d ). MAML1 recruits p300 to the CSL-Notch transcriptional complex (Saint Just et al., 2007) . When we transfected MCF-7 cells with DN-MAML1, the interaction between ERa and p300 was inhibited (Figure 6e ). These data support a model in which in the absence of E 2 MAML1 rather than p160-family coactivators is responsible for Notch-1-induced p300 recruitment to ERa-dependent promoters.
Discussion
We describe a novel crosstalk between Notch-1 and ERa, whereby Notch-1 transactivates a subset of ERa-responsive genes via a mechanism that requires IKKa and MAML1, but not SRC1 or SRC3. The working model supported by our data is shown in Figure 7 . The transcriptional effects of Notch activation are notoriously context-dependent. Part of this context dependence may result from a complex interplay between the Notch transcriptional complex (NTC) and other cell type-specific transcription factors. Evidence (Nam et al., 2007) supports a model in which two DNAbound NTCs bind cooperatively to some Notchresponsive genes. Our data suggest that the NTC is also capable of forming complexes with ERa. Thus, in breast cancer cells, the effects of Notch activation would depend on ERa expression and E 2 concentration. Estrogen receptor-a can regulate transcription positively and negatively, and it can bind DNA directly via EREs or other transcription factors such as AP1 or SP1 . Pioneer factors such as FoxA1 play a key role in recruiting ERa to specific DNA sites upon E 2 treatment (Laganiere et al., 2005) . ERa-binding DNA sites can be found as far as 50-100 kb from regulated genes (Lin et al., 2007) . Several sites can cooperate in the regulation of individual genes . A widely accepted model of E 2 regulation of cyclin-D1 suggests that recruitment of FoxA1 to a downstream enhancer facilitates E 2 -activated binding of ERa to this site and additional upstream sites (Laganiere et al., 2005) . Among these, an AP1 site at À934 recruits ERa and p300. This site is contained in the amplicon that we analysed (P2 site in Figure 1f ), as is a putative ERE. A bioinformatic scan of the human and mouse genomes revealed that canonical EREs are found at specific spacing distances from CSLresponsive elements with highly statistically significant frequencies (Supplementary Figure 7) . Many of these sequence pairs are found within 2 kb of genes conserved between humans and mice (not shown). Genome-wide studies will be necessary to determine which of these genes are co-regulated by Notch-1 and ERa, which subset of the known ERa binding sites is close to CSL responsive elements, whether Notch-1 influences DNA site usage by ERa, and whether AP1-tethered or SP1-tethered ERa also cooperate with Notch-1. This is possible, based on our data on the cyclin-D1 and c-Myc promoters. Notch-1 is recruited both by E 2 and by Jagged-1 to a region in the cyclin-D1 promoter known to bind ERa via AP1 (Shen et al., 2008) .
The SP1 site in the c-Myc promoter thought to be important in mediating E 2 transcriptional effects is very close to our amplicon (Dubik and Shiu, 1992) . We focused on a relatively small and well-characterized promoter, pS2, whose active regulatory elements are found in the vicinity of the transcriptional start.
Our data demonstrate a key role for nuclear IKKa in Notch-1-ERa cooperation. IKKa stimulates ERa activity in the presence of E 2 (Park et al., 2005) , by phosphorylating ERa and/or histone H3, and is necessary for transcriptional induction of cyclin-D1 by mitogenic signals (Albanese et al., 2003) . We have previously shown that in CaSki cervical cancer cells, Notch-1 associates with IKKa and is required for its recruitment to the c-IAP2 promoter (Song et al., 2008) . This study indicates that IKKa is found in association with ERa and MAML1 in the nucleus only in the presence of Notch-1. Taken together, these findings suggest that promoting the chromatin recruitment of IKKa is a novel function of Notch-1, through which Notch-1 can mediate crosstalk with other transcription factors. IKKa has been suggested to regulate Notch signaling via phosphorylation of nuclear IkBa in 3T3 cells (Aguilera et al., 2004) . Abnormal IKKa activity in colon cancer cells was reported to increase Notch transcriptional activity (Fernandez-Majada et al., 2007) . Our data from CaSki cells (Song et al., 2008) are consistent with that model. However, in MCF-7 cells, IKKa was not required for Notchmediated induction of HEY1, whereas being absolutely required for crosstalk with ERa. It is likely that the accessory role of IKKa in Notch signaling depends on cell type and target genes.
A physical association between Notch-1 and a nuclear receptor, Nur77, was shown in 1999 in T-cells (Jehn et al., 1999) . In our model, the interaction between the Notch-1 and ERa transcriptional complexes appears to require DNA, and is likely to be indirect. However, direct contact between Notch-1 and DNA-bound ERa may contribute to complex formation.
The possible physiological role of Notch in ERa signaling deserves further investigation. Under our experimental conditions, Notch-1 knockdown inhibits c-Myc basal expression in the presence, but not absence, of E 2 , whereas for pS2 and cyclin-D1, Notch-1 is required for (MAM) and other coactivators (not shown for clarity) binds to Notch-CSL-responsive elements (NCRE). IKKa is recruited to the NTC in a Notch-dependent manner, although it is still unclear whether the interaction with Notch is direct and is necessary for formation of the supramolecular complex. ERa is recruited to the nucleus in a Notch-1-dependent manner, binds to its responsive element (ERE) or possibly through other transcription factors or pioneer factors, and is necessary for NTC recruitment to ERaresponsive genes. In the absence of E 2 , MAML1 recruits p300 to the complex, taking over the functions normally carried out by p160 ERa coactivators. The formation of a supramolecular complex between the NTC and the ERa transcriptional complex contributes to activate transcription of a subset of ERa-responsive genes in the absence of E 2 , and for some genes also in its presence. The pol-II complex is depicted at the TATA box with its most important components. The angled green arrow indicates transcriptional start. ER, estrogen receptor; ERa, estrogen receptor-a.
Notch activates ERa-dependent transcription L Hao et al expression in the presence or absence of E 2 (Supplementary Figure 8) . Knockdown of either Notch-1 or IKKa prevents transactivation of cyclin-D1 and pS2 by E 2 (Supplementary Figure 9) . This suggests that Notch-1 may be a physiological cofactor of E 2 for some ERa-target genes, whereas for other genes Notch-1 may be sufficient to activate ERamediated transcription even in the absence of E 2 . The latter phenomenon may be pathogenetically important in endocrine-resistant breast cancers. Physiologically, this effect may contribute to luminal differentiation during mammary gland development, as Notch-1 has been shown to play a role in ERa expression during luminal cell fate determination (Dontu et al., 2004; Bouras et al., 2008) . We have recently shown that in breast cancer cells E 2 inhibits Notch activation and E 2 withdrawal reactivates Notch. This study shows that Notch can activate ERa-dependent transcription, suggesting the existence of a feedback mechanism controlling the Notch-ERa crosstalk.
These findings have significant therapeutic implications. We have shown that anti-estrogens or estrogen withdrawal increases the dependence of breast cancer cells on Notch. Notch-1 knockdown inhibited the growth of MCF-7 cells in charcoal-stripped serum as potently as fulvestrant (Supplementary Figure 10) . We have previously shown that NIC induces proliferation in these cells . However, we did not observe accelerated CFSE dilution (a measure of doubling time) in co-culture assays with Jagged-1-expressing fibroblasts (not shown). Thus, it is possible that the main effect of Notch-1 in this setting is to maintain survival, thus allowing proliferation, rather than directly accelerating proliferation.
We confirmed that regulation of E 2 -target genes by Notch is not limited to MCF-7 cells, and can be observed in T47D:A18 cells as well (Supplementary Figure 11) . Similarly, in T47:A18 xenografts treated with tamoxifen and an oral GSI, pS2 expression was downregulated more effectively than canonical Notch-target genes (Supplementary Figure 12 ), indicating that inhibition of E 2 -target genes may mediate the effects of GSIs in ERa-positive breast cancers and may be an efficacy biomarker. Finally, our study suggests that targeting IKKa, alone or with Notch, may affect the expression of ERa-target genes without further decreasing the expression of canonical Notch-target genes. This may allow us to circumvent or reduce, thus, the systemic toxicity of Notch inhibitors while selectively affecting breast cancer cells.
Materials and methods
Cell culture MCF-7 cells from ATCC were grown in RPMI with 10% fetal bovine serum and 6 ng/ml insulin. LTK-PAR and LTKJagged-1 cells were generously provided by Dr G Weinmaster (University of California at Los Angeles, Los Angeles, CA, USA) were expanded in Dulbecco's Modified Eagle's Medium with 10% fetal bovine serum.
